Faltering growth / failure to thrive

Faltering growth in children: assessment and management in AU general practice

Faltering growth (preferred over "failure to thrive") means a child's weight gain is inadequate for age, defined by NICE NG75 as a fall across one or more centile spaces on weight-for-age. Around 85 per cent of cases are caused by inadequate caloric intake — over-dilution of formula, breastfeeding difficulties, or food insecurity — rather than underlying disease.

Assessment requires accurate plotting on the WHO 0–5 year chart, a detailed feeding history, and targeted blood tests. Management centres on a multidisciplinary team including GP, paediatrician, dietitian, and social worker, alongside calorie supplementation, responsive feeding strategies, and addressing social determinants.

Faltering growth affects approximately five to ten per cent of Australian infants seen in general practice. Most cases resolve with structured outpatient care, but missing the diagnosis — or missing the social determinants driving it — leads to prolonged undernutrition with lasting effects on neurodevelopment and immune function. The RCH Melbourne faltering growth guideline and NICE NG75 form the clinical anchors for Australian general practice.

A. Core clinical — the AU general-practice framework

Terminology and severity classification

“Faltering growth” has largely replaced “failure to thrive” in contemporary Australian paediatric practice, following NICE NG75 (2017) and AAP 2020 guidance. The updated term is less stigmatising and directs clinical attention to the trajectory on the growth chart rather than implying a parenting failure.

NICE NG75 severity definitions (based on centile-space falls on weight-for-age):

  • Mild — fall across one or more centile spaces in an infant born above the ninth centile (birth weight above minus one standard deviation)
  • Moderate — fall across two or more centile spaces
  • Severe — fall across three or more centile spaces, or weight below the 0.4th centile at any time

Growth charts in Australia

Plot under two years of age on the WHO 0–5 year growth standard — a multinational, optimally breastfed reference population that represents physiological growth. From two years onwards, use Australian or CDC reference charts as per RCH guidelines. For preterm infants, apply corrected age until two years of chronological age. Using the wrong chart or forgetting prematurity correction are the most common reasons faltering growth is over- or under-diagnosed.

Distinguish faltering growth (weight-for-age trajectory falling across centiles) from short stature (height-for-age restriction) and acute wasting (sudden weight-for-height drop). Calculate mid-parental height [(father + mother heights) ÷ 2, then +6.5 cm for boys or −6.5 cm for girls]: a child tracking the third centile with parents of small stature may simply reflect familial constitution.

Aetiology — the four mechanisms

Faltering growth is mechanistically a calorie deficit, arising from one of four pathways (eTG paediatrics, AAP Homan 2016):

Inadequate intake (~85 per cent) — the dominant category, and usually correctable. Causes include over-dilution of infant formula (the single most common correctable error), breastfeeding difficulties (latch, supply, tongue-tie), food refusal or avoidant/restrictive food intake disorder, oral-motor dysfunction, neglect, parental mental health problems, and food insecurity.

Increased caloric demand (<10 per cent) — congenital heart disease, chronic lung disease (bronchopulmonary dysplasia, cystic fibrosis), chronic infection (recurrent urinary tract infection, TB, HIV), hyperthyroidism, severe eczema, and malignancy.

Excessive losses or malabsorption (<10 per cent) — coeliac disease, cow’s milk allergy, cystic fibrosis with pancreatic insufficiency, inflammatory bowel disease, chronic diarrhoea, and significant gastro-oesophageal reflux with vomiting.

Decreased utilisation (<5 per cent) — inborn errors of metabolism, hypothyroidism, growth hormone deficiency, chromosomal conditions (Down syndrome, Turner syndrome, Prader-Willi syndrome).

Assessment

History is the highest-yield component of assessment. Cover:

  • Feeding history in detail: breast versus formula versus mixed; if formula, how is it being reconstituted (exact scoops per mL, levelled or heaped, brand); volume and frequency; latch and oral-motor function; progression to solids
  • Three-day food diary — prospectively collected, ideally, on a typical and atypical day
  • Symptoms: stool frequency and consistency (steatorrhoea suggests cystic fibrosis or coeliac), vomiting pattern, wet nappies, recurrent infections
  • Growth trajectory: birth weight, length, head circumference, gestational age, all parental heights
  • Psychosocial screen: parental mental health, family violence, food insecurity, housing, ATSI or refugee background, parental drug and alcohol use, family support network

Examination: full anthropometry at every visit — weight, length (lying) or height (standing), head circumference under three years, BMI from two years — plotted on the appropriate chart. Assess nutritional status (subcutaneous fat loss over cheeks, buttocks, thighs; prominent ribs), dysmorphic features, cardiovascular and respiratory signs, abdominal distension, skin (eczema, pallor, bruising), mouth (palate, tongue-tie, dental health), tone and developmental observation.

Investigations should be targeted, not routine in mild cases where intake history is clear (NICE NG75). When organic cause is suspected or severity is moderate to severe, request:

  • FBC (MBS 65070), UEC and glucose (MBS 66500), LFTs and albumin (MBS 66509), TSH and free T4 (MBS 66716)
  • Anti-tTG IgA plus total IgA (coeliac screen) — note the child must be consuming gluten for valid serology
  • Iron studies, ferritin, vitamin B12, folate, vitamin D, calcium, zinc
  • Urinalysis and microscopy, culture, and sensitivities
  • Faecal calprotectin and faecal elastase if diarrhoea or suspected malabsorption
  • Sweat chloride test if cystic fibrosis is possible (recurrent chest infections, steatorrhoea, salty skin, or family history — note newborn screening catches most but not all cases)

Red flags requiring same-day referral or hospital admission

  • Weight below the 0.4th centile or BMI below minus three standard deviations
  • Dehydration or electrolyte disturbance
  • Suspected non-accidental injury or safeguarding concern — mandatory notification to state child protection authority is required
  • Cyanosis, tachypnoea, heart failure, or severe respiratory distress
  • Suspected metabolic crisis (vomiting, lethargy, hypoglycaemia, acidosis)
  • Faltering growth that is refractory to optimised outpatient management

B. Evidence appraisal

The WHO 0–5 year growth standard is strongly preferred over the CDC 2000 reference for Australian children under two years — it is derived from optimally breastfed children across multiple ethnic groups and represents a physiological growth standard rather than a population reference. Switching to the Australian or CDC chart at two years avoids apparent centile shifts from changing reference populations.

NICE NG75 supports outpatient multidisciplinary management as the default approach — approximately 80 per cent of children respond without hospitalisation. Admission should be reserved for the red-flag indications above, not used routinely. Routine hospitalisation does not address the social determinants that drive the majority of cases.

Coeliac serology (anti-tTG IgA plus total IgA) is recommended as standard screening when there is no clear intake-driven explanation, because coeliac disease is present in approximately five to ten per cent of unexplained faltering growth cases and is fully treatable. The child must be consuming a gluten-containing diet for accurate results.

Polymeric oral nutritional supplements — PaediaSure and equivalent products — have observational support for catch-up growth in children with malabsorption or medical conditions. A food-first approach (energy-dense whole foods before supplements) is preferred for mild to moderate cases, per Australian dietetic practice, to avoid supplements displacing the child’s appetite for normal food. Manary Cochrane 2013 supports ready-to-use therapeutic foods in severe undernutrition settings. Goldenberg Cochrane 2017 shows a modest signal for probiotics in acute diarrhoea; evidence in chronic faltering growth is weaker.

Force-feeding is consistently associated with worse outcomes — it entrench aversion, damages the parent–child relationship around mealtimes, and undermines long-term intake regulation. Responsive feeding (Satter’s division of responsibility: parent decides what, when, and where; child decides whether and how much) is the evidence-based behavioural framework.

C. Australian operations — MBS, PBS, and referral pathways

MBS billing (MBS Online):

Faltering growth qualifies as a chronic condition for a GP Chronic Condition Management Plan (GPCCMP) — item 965 for the plan, item 967 for a review. A GPCCMP allows up to five allied health sessions per year under the 10950 series: dietitian 10954, speech pathology 10970, occupational therapy 10958, psychology 10968. Standard GP consults: 23 (short), 36 (standard), 44 (long) — a long consult is appropriate for the initial assessment given the depth of history required.

For ATSI families, the annual health assessment item 715 provides a comprehensive review including growth, immunisation, and referral pathways aligned with Closing the Gap targets. The Healthy Kids Check (item 709) at four years covers growth, vision, hearing, and behavioural screen.

A Mental Health Treatment Plan (items 2715 and 2717) allows up to ten psychology sessions per year via Better Access — applicable for parental depression or anxiety identified during assessment, or for child feeding-aversion behavioural intervention.

PBS supplements (PBS Online):

  • PaediaSure (polymeric formula 1.0 or 1.5 kcal/mL) — PBS Authority Required for faltering growth with malabsorption, oncology, or prolonged illness in children aged one to ten years
  • Nutramigen / Aptamil Pepti (extensively hydrolysed formula) — PBS Authority Required for confirmed or strongly suspected cow’s milk allergy
  • Neocate / EleCare (amino-acid formula) — PBS Authority Required with restricted prescribers and specific medical condition certification for severe cow’s milk allergy or multiple food protein allergy
  • Levothyroxine — PBS general listing for hypothyroidism
  • Creon (pancreatic enzyme replacement) — PBS Authority Required for cystic fibrosis or documented exocrine pancreatic insufficiency

Referral pathways:

  • Severe wasting, dehydration, electrolyte issues, suspected non-accidental injury → paediatric emergency department, same day
  • Moderate faltering or suspected organic cause → general paediatrician plus dietitian within four weeks
  • Suspected coeliac or cow’s milk allergy → paediatric gastroenterology plus dietitian within four weeks
  • Suspected cystic fibrosis → paediatric respiratory or CF service within one to two weeks
  • Breastfeeding difficulties → International Board Certified Lactation Consultant (IBCLC), Tresillian, Karitane, or Australian Breastfeeding Association helpline
  • ATSI families → ACCHS or AMS plus ATSI Maternal Child Health Worker at first contact; Closing the Gap pathways
  • Refugee or CALD families → refugee health nurse plus accredited interpreter at first contact
  • Parental mental health or family violence → MHCP referral plus 1800 RESPECT; social work

D. Integrative and lifestyle considerations

Food-first energy supplementation is the cornerstone of management in mild to moderate faltering growth and requires no prescription. A paediatric dietitian guides specific calorie targets (120–150 per cent of estimated energy requirement for catch-up growth) and recommends energy-dense whole foods: full-fat dairy, butter, avocado, olive oil, nut butters, cream cheese, and eggs added to existing meals rather than replacing lower-calorie foods. Reducing excess cow’s milk (cap at 500 mL per day in toddlers, as excess milk displaces solids and causes iron deficiency), juice, and weak cordial frees appetite for calorie-dense foods.

Responsive feeding — the Satter division of responsibility — is the evidence-based behavioural framework. The parent decides what food is offered, when meals occur, and where eating takes place. The child decides whether to eat and how much. Structured mealtimes of 20 to 30 minutes at the table with the family, without screens, with repeated low-pressure exposure to new foods, and praise for trying rather than finishing the plate, form the practical implementation. No force-feeding under any circumstances.

Social determinant intervention is often the single lever that actually moves the weight curve. Food insecurity connects to Foodbank, community pantries, financial counselling, and Centrelink advocacy. Parental mental health is addressed via an MHCP and Better Access psychology. Family violence triggers universal enquiry, safety planning, and 1800 RESPECT referral. Housing instability warrants social work referral. Closing the Gap food security initiatives and ATSI Maternal Child Health Workers provide culturally safe pathways for Aboriginal and Torres Strait Islander families.

Formula concentration adjustment — if formula is over-diluted, correcting to standard reconstitution often resolves faltering growth without any further intervention. Concentration increases (to approximately one scoop per 25–28 mL) can be trialled under dietitian guidance for short periods, with monitoring of renal solute load.

Probiotics as an adjunct for chronic non-specific diarrhoea contributing to faltering growth have a modest evidence base (Goldenberg Cochrane 2017) and are generally low-risk, but should not replace targeted investigation or a cause-directed management plan.

E. Special populations

Aboriginal and Torres Strait Islander children have a disproportionate burden of faltering growth in Australia, driven by food insecurity, high infection burden (including recurrent otitis media with secondary anaemia), and structural social disadvantage. ACCHS and AMS engagement, ATSI Maternal Child Health Workers, and culturally appropriate dietetic resources are first-line pathways. The ATSI annual health check (MBS 715) provides a framework for systematic growth surveillance. Closing the Gap targets include infant nutrition outcomes — engage with local co-commissioning arrangements.

Preterm infants show a physiologically expected centile drop in the first weeks post-discharge as they transition to post-natal growth patterns. Plot corrected age until two years chronological age; over-diagnosing faltering growth in preterm infants who are tracking appropriately for corrected age leads to unnecessary intervention and parental anxiety.

Refugee and CALD children may present with dietary practices, feeding patterns, and growth norms unfamiliar to the clinician. Accredited interpreters are mandatory for any clinical assessment. Refugee health nurses and community health workers provide cultural liaison and practical food support.

Adolescents with faltering growth warrant consideration of eating disorders (anorexia nervosa, ARFID) alongside organic causes — involve paediatric or adolescent psychiatry where indicated, alongside the standard medical workup.

Syndromic or chromosomal conditions (Down syndrome, Turner syndrome, Prader-Willi syndrome, Russell-Silver syndrome) have condition-specific growth charts; standard WHO and Australian charts are not appropriate references. Refer to paediatric genetics or the relevant specialist growth chart.

When to escalate

Seek same-day paediatric emergency assessment when a child shows weight below the 0.4th centile, dehydration, electrolyte disturbance, cardiopulmonary compromise, suspected non-accidental injury, or signs of metabolic crisis. Non-accidental injury must also trigger a mandatory notification to the relevant state child protection authority regardless of whether the child is transferred.

Escalate to a general paediatrician within four weeks for moderate faltering growth, any suspicion of organic disease, or faltering growth that has not improved with an initial six to eight weeks of optimised outpatient MDT management.

Review weekly for the first four to six weeks of any intervention, then fortnightly while the trajectory is improving, then monthly. A plateau or further fall in weight despite an optimised plan at six to eight weeks is an indication to escalate regardless of the initial severity classification.

What this article is and is not

This article synthesises Australian and international evidence-based guidelines on faltering growth to support informed conversations between patients, carers, and clinicians. It is for educational purposes and does not constitute medical advice for any individual child. Growth assessments and management plans require a qualified health professional who can evaluate the specific clinical context, apply current guidelines, and respond to changes over time. Parents who are concerned about their child’s growth should seek assessment from their GP, child and family health nurse, or paediatrician.


Sources cited

  1. RCH Melbourne — Failure to thrive / faltering growth CPG
  2. NICE NG75 — Faltering growth: recognition and management (2017)
  3. eTG complete — Paediatrics: faltering growth
  4. NHMRC Eat for Health — Infant Feeding Guidelines
  5. WHO Child Growth Standards (0–5 y)
  6. Coeliac Australia — Faltering growth screening
  7. Closing the Gap — National Agreement on Closing the Gap
  8. AAP Failure to Thrive Clinical Report 2020 / Homan AFP 2016
  9. Manary Cochrane 2013 — Ready-to-use therapeutic food for undernutrition
  10. Goldenberg Cochrane 2017 — Probiotics for diarrhoea
  11. MBS Online — items 23, 36, 44, 709, 715, 965, 967, 10950 series, 2715, 2717, 65070, 66500, 66509, 66716, 71163
  12. PBS Online — PaediaSure, Nutramigen, Neocate, levothyroxine, Creon

Frequently asked questions

  • What is the difference between faltering growth and 'failure to thrive'?

    They describe the same condition. 'Failure to thrive' is an older term now largely replaced by 'faltering growth' following NICE NG75 (2017) and AAP guidance. The updated language is less stigmatising for families, as it emphasises the child's growth trajectory on a chart rather than implying parental failure. Australian guidelines from RCH Melbourne and the RACGP now use 'faltering growth' as the standard term. The diagnostic criteria and management pathway are the same.

  • How do I know which growth chart to use for my child in Australia?

    Australian guidelines recommend the WHO 0–5 year growth standard for children under two years of age — it uses an optimally breastfed, multinational reference population. From two years onwards, the Australian or CDC reference chart is used. For preterm infants, the corrected age (adjusted for weeks of prematurity) should be used for plotting until two years of chronological age. Using the wrong chart or failing to correct for prematurity are the most common plotting errors that lead to unnecessary concern or missed diagnoses.

  • When should a child with faltering growth be admitted to hospital?

    Hospital admission is needed when a child has severe wasting (weight below the 0.4th centile or BMI below minus three standard deviations), dehydration or electrolyte disturbance, suspected non-accidental injury or significant safeguarding concern, cardiopulmonary signs such as cyanosis or heart failure, or when faltering growth is refractory to optimised outpatient management. Around 80 per cent of children respond to structured outpatient multidisciplinary care. Admission alone without addressing social determinants rarely resolves the underlying problem.

  • Is formula concentration adjustment safe for a baby with poor weight gain?

    Adjusting formula concentration should only be done under guidance from a paediatric dietitian. The standard ratio is one scoop per 30 mL of water. Modest concentration increases — up to approximately one scoop per 25–28 mL — can be trialled for short periods under monitoring, as higher concentrations increase the renal solute load on a baby's kidneys. Over-dilution (adding too much water) is actually the most common formula error seen in faltering growth. Never change formula concentration without professional guidance.

  • Can parents address faltering growth by force-feeding their child?

    Force-feeding is not recommended and can cause harm. It entrenches feeding aversion, damages the parent–child relationship around mealtimes, and undermines the child's long-term ability to self-regulate their intake. Responsive feeding — where the parent decides what food is offered, when, and where, and the child decides whether to eat and how much — is the evidence-based approach. Structured mealtimes of 20–30 minutes without screens, repeated exposure to new foods without pressure, and praise for trying rather than finishing the plate are the recommended strategies.

  • What PBS-subsidised supplements are available for children with faltering growth?

    Several paediatric oral nutritional supplements are available on the PBS with Authority Required prescriptions for specific medical conditions. PaediaSure (a polymeric formula providing 1.0 or 1.5 kilocalories per millilitre) is PBS-listed for faltering growth with malabsorption or prolonged illness in children aged one to ten years. Extensively hydrolysed formulas such as Nutramigen are PBS-funded for confirmed cow's milk allergy. Amino-acid formulas such as Neocate are PBS-listed for severe cow's milk allergy or multiple food protein allergy, with restricted prescriber and certification requirements. A paediatric dietitian determines which product is appropriate.

Source quality

Sources grouped by evidence tier. AU primary tier first; international where AU is silent or lagging; named-author reconstruction where guidelines have not yet caught up. How tiers work.